Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.
Cancers (Basel). 2023 May 29;15(11):2964. doi: 10.3390/cancers15112964.
Cancers (Basel). 2023.
PMID: 37296925
Free PMC article.
Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP).
Alegre A, Benzo G, Alonso R, Martínez-López J, Jimenez-Ubieto A, Cuéllar C, Askari E, Prieto E, Aláez C, Aguado B, Velasco A, Krsnik I, Bocanegra A, Llorente L, Muñoz-Linares C, Morales A, Giménez E, Iglesias R, Martínez-Chamorro C, Alonso A, Jiménez-Montes C, Blanchard MJ; Grupo GM-GM.
Alegre A, et al.
Oncol Ther. 2023 Mar;11(1):83-96. doi: 10.1007/s40487-022-00212-5. Epub 2022 Dec 12.
Oncol Ther. 2023.
PMID: 36509945
Free PMC article.
Item in Clipboard
Pressure-driven flow through a single nanopore.
Velasco AE, Friedman SG, Pevarnik M, Siwy ZS, Taborek P.
Velasco AE, et al.
Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Aug;86(2 Pt 2):025302. doi: 10.1103/PhysRevE.86.025302. Epub 2012 Aug 22.
Phys Rev E Stat Nonlin Soft Matter Phys. 2012.
PMID: 23005817
Item in Clipboard
Cite
Cite